Featured Publications
Cat Scratch Disease: 9 Years of Experience at a Pediatric Center
Amin O, Rostad CA, Gonzalez M, Rostad BS, Caltharp S, Quincer E, Betke BA, Gottdenker NL, Wilson JJ, Shane AL, Elmontser M, Camacho-Gonzalez A, Senior T, Smith O, Anderson EJ, Yildirim I. Cat Scratch Disease: 9 Years of Experience at a Pediatric Center. Open Forum Infectious Diseases 2022, 9: ofac426. PMID: 36072697, PMCID: PMC9439574, DOI: 10.1093/ofid/ofac426.Peer-Reviewed Original ResearchCat-scratch diseaseClinical featuresAtypical clinical manifestationsPediatric hospital systemMajority of casesPediatric centersAtypical presentationCanine exposureCat exposureMedian ageRegional lymphadenopathyClinical manifestationsHepatic microabscessesPhysical examinationScratch diseaseMedical recordsPolymerase chain reactionRisk factorsSchool-aged childrenRetrospective analysisCytopathological resultsPatient careLymphadenopathyRadiographic imagingHospital system
2024
Leveraging real-world Data from administrative claims and medical records to inform safety and effectiveness of piperacillin-tazobactam in the Management of Pediatric Hospital Acquired Pneumonia
Blumenstock J, Faerber J, Menon M, Lawler R, Downes K, Kratz E, Erickson K, Haltzman-Cassenti B, Yildirim I, Hussaini L, Elmontser M, Sederdahl B, Hahn A, Thomson J, Newland J, Terrill C, Bradley J, Zachariah P, Younus M, Mo J, Wible M, Tawadrous M, Fisher B. Leveraging real-world Data from administrative claims and medical records to inform safety and effectiveness of piperacillin-tazobactam in the Management of Pediatric Hospital Acquired Pneumonia. American Journal Of Epidemiology 2024, kwae251. PMID: 39108170, DOI: 10.1093/aje/kwae251.Peer-Reviewed Original ResearchIncidence rate ratiosPediatric Health Information SystemHospital-acquired pneumoniaMedical recordsHealth information systemsPoisson regression modelsBetween-group differencesStudy combined dataEffects of medicationAdministrative claimsRate ratiosClinical improvementSecondary outcomesBetween-groupEffect of piperacillin-tazobactamComparative riskReal World DataHospital acquired pneumoniaRegression modelsTreating hospital-acquired pneumoniaOff-label settingCIPediatric institutionControlled studiesPiperacillin-tazobactam